Search
Now showing items 1-1 of 1
Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix1) Pilot Project in Uganda
(2016)
The objective of this study was to determine the prevalence and some predictors for vaccine
and non-vaccine types of HPV infections among bivalent HPV vaccinated and non-vaccinated
young women in Uganda. This was a ...